News about Jamie Walters

Novo Nordisk's Wegovy may be the pharma industry's biggest golden ticket yet, with some analysts predicting that the growing market will rake in over $100 billion in sales in the upcoming decade. Already an estimated 40% of American adults are obese, which qualifies them for one of the blockbuster drugs, and the majority of us are likely to be obese by 2030, pushing the number even higher. So, what are they?And how many people take them?And do they work? Your questions have been answered in the Daily Mail.